Jeffrey Hrkach

Jeffrey Hrkach

Chief Tech/Sci/R&D Officer at Nvelop Therapeutics, Inc.

58 year
Health Technology
Consumer Services
Finance

Profile

Jeffrey Hrkach is currently an Advisor at Atlas Venture Advisors, Inc. and the Chief Technology Officer at Nvelop Therapeutics, Inc. He previously worked as the Director-Pulmonary Formulations at Alkermes, Inc., Senior Director-Drug Delivery at Momenta Pharmaceuticals, Inc., Manager at Sandoz, Inc., Principal at Novartis AG, and Senior Vice President-Technology Development at Frequency Therapeutics, Inc. He also served as the Chief Technology Officer at DNIB Unwind, Inc. from 2007 to 2014.
Dr. Hrkach holds a doctorate degree from Carnegie Mellon University and an undergraduate degree from Philadelphia College of Pharmacy.

Jeffrey Hrkach active positions

CompaniesPositionStart
Consultant / Advisor 2022-02-28
Chief Tech/Sci/R&D Officer 2022-02-28
All active positions of Jeffrey Hrkach

Former positions of Jeffrey Hrkach

CompaniesPositionEnd
DNIB UNWIND INC Chief Tech/Sci/R&D Officer 2014-11-30
KORRO BIO, INC. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
NOVARTIS AG Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jeffrey Hrkach's experience

Training of Jeffrey Hrkach

Carnegie Mellon University Doctorate Degree
Philadelphia College of Pharmacy Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Hrkach's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
NOVARTIS AG

Health Technology

Private companies7

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Jeffrey Hrkach